APA (7th ed.) Citation

M, F., E, J., S, S., H, A., A, P., GJR, C., . . . T, W. (2025). The utility of [18F]FDG PET in discriminating between local recurrence and inflammatory changes following SABR in primary lung cancer patients. European journal of nuclear medicine and molecular imaging, 53(1), 181. https://doi.org/10.1007/s00259-025-07400-1

Chicago Style (17th ed.) Citation

M, Fala, Josephides E, Shah S, Ariyaratne H, Patel A, Cook GJR, Chicklore S, and Wagner T. "The Utility of [18F]FDG PET in Discriminating Between Local Recurrence and Inflammatory Changes Following SABR in Primary Lung Cancer Patients." European Journal of Nuclear Medicine and Molecular Imaging 53, no. 1 (2025): 181. https://doi.org/10.1007/s00259-025-07400-1.

MLA (9th ed.) Citation

M, Fala, et al. "The Utility of [18F]FDG PET in Discriminating Between Local Recurrence and Inflammatory Changes Following SABR in Primary Lung Cancer Patients." European Journal of Nuclear Medicine and Molecular Imaging, vol. 53, no. 1, 2025, p. 181, https://doi.org/10.1007/s00259-025-07400-1.